nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—ulcerative colitis	0.448	1	CbGaD
Linagliptin—CYP3A4—Budesonide—ulcerative colitis	0.0645	0.147	CbGbCtD
Linagliptin—ABCB1—Methylprednisolone—ulcerative colitis	0.0481	0.11	CbGbCtD
Linagliptin—ABCB1—Betamethasone—ulcerative colitis	0.0313	0.0713	CbGbCtD
Linagliptin—ABCB1—Prednisolone—ulcerative colitis	0.0309	0.0704	CbGbCtD
Linagliptin—ABCB1—Hydrocortisone—ulcerative colitis	0.0293	0.0667	CbGbCtD
Linagliptin—ABCB1—Prednisone—ulcerative colitis	0.0291	0.0665	CbGbCtD
Linagliptin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0288	0.0657	CbGbCtD
Linagliptin—CYP3A4—Nicotine—ulcerative colitis	0.0281	0.0641	CbGbCtD
Linagliptin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0252	0.0575	CbGbCtD
Linagliptin—CYP3A4—Triamcinolone—ulcerative colitis	0.0218	0.0498	CbGbCtD
Linagliptin—CYP3A4—Betamethasone—ulcerative colitis	0.0187	0.0427	CbGbCtD
Linagliptin—CYP3A4—Prednisolone—ulcerative colitis	0.0185	0.0422	CbGbCtD
Linagliptin—ABCB1—Dexamethasone—ulcerative colitis	0.0182	0.0415	CbGbCtD
Linagliptin—CYP3A4—Hydrocortisone—ulcerative colitis	0.0175	0.04	CbGbCtD
Linagliptin—CYP3A4—Prednisone—ulcerative colitis	0.0175	0.0398	CbGbCtD
Linagliptin—CYP3A4—Dexamethasone—ulcerative colitis	0.0109	0.0249	CbGbCtD
Linagliptin—Pancreatitis acute—Mesalazine—ulcerative colitis	0.00244	0.0215	CcSEcCtD
Linagliptin—Diabetic—Hydrocortisone—ulcerative colitis	0.0024	0.0212	CcSEcCtD
Linagliptin—Diabetic—Methylprednisolone—ulcerative colitis	0.00226	0.0199	CcSEcCtD
Linagliptin—Diabetic—Betamethasone—ulcerative colitis	0.00205	0.0181	CcSEcCtD
Linagliptin—Diabetic—Dexamethasone—ulcerative colitis	0.00205	0.0181	CcSEcCtD
Linagliptin—Pancreatitis acute—Hydrocortisone—ulcerative colitis	0.00174	0.0153	CcSEcCtD
Linagliptin—Pancreatitis acute—Betamethasone—ulcerative colitis	0.00148	0.0131	CcSEcCtD
Linagliptin—Pancreatitis acute—Dexamethasone—ulcerative colitis	0.00148	0.0131	CcSEcCtD
Linagliptin—Nasopharyngitis—Nicotine—ulcerative colitis	0.00131	0.0115	CcSEcCtD
Linagliptin—Pancreatitis acute—Prednisone—ulcerative colitis	0.00129	0.0114	CcSEcCtD
Linagliptin—Pancreatitis—Mercaptopurine—ulcerative colitis	0.00128	0.0113	CcSEcCtD
Linagliptin—Weight increased—Nicotine—ulcerative colitis	0.00115	0.0101	CcSEcCtD
Linagliptin—Skin exfoliation—Mesalazine—ulcerative colitis	0.00108	0.00948	CcSEcCtD
Linagliptin—Hypertriglyceridaemia—Prednisone—ulcerative colitis	0.00104	0.00915	CcSEcCtD
Linagliptin—Immune system disorder—Mercaptopurine—ulcerative colitis	0.000942	0.0083	CcSEcCtD
Linagliptin—Immune system disorder—Nicotine—ulcerative colitis	0.000913	0.00805	CcSEcCtD
Linagliptin—Mediastinal disorder—Nicotine—ulcerative colitis	0.000911	0.00803	CcSEcCtD
Linagliptin—Blood triglycerides increased—Prednisone—ulcerative colitis	0.00091	0.00802	CcSEcCtD
Linagliptin—Malnutrition—Mercaptopurine—ulcerative colitis	0.000908	0.008	CcSEcCtD
Linagliptin—Nasopharyngitis—Budesonide—ulcerative colitis	0.0009	0.00793	CcSEcCtD
Linagliptin—Back pain—Nicotine—ulcerative colitis	0.000851	0.0075	CcSEcCtD
Linagliptin—Angioedema—Nicotine—ulcerative colitis	0.000804	0.00708	CcSEcCtD
Linagliptin—Weight increased—Budesonide—ulcerative colitis	0.000792	0.00697	CcSEcCtD
Linagliptin—Infestation NOS—Budesonide—ulcerative colitis	0.000776	0.00683	CcSEcCtD
Linagliptin—Infestation—Budesonide—ulcerative colitis	0.000776	0.00683	CcSEcCtD
Linagliptin—Arthralgia—Mercaptopurine—ulcerative colitis	0.000773	0.00681	CcSEcCtD
Linagliptin—Cough—Nicotine—ulcerative colitis	0.000768	0.00677	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000768	0.00677	CcSEcCtD
Linagliptin—Skin exfoliation—Hydrocortisone—ulcerative colitis	0.000765	0.00674	CcSEcCtD
Linagliptin—Pancreatitis—Azathioprine—ulcerative colitis	0.000761	0.00671	CcSEcCtD
Linagliptin—Urinary tract infection—Budesonide—ulcerative colitis	0.000754	0.00664	CcSEcCtD
Linagliptin—Arthralgia—Nicotine—ulcerative colitis	0.000749	0.0066	CcSEcCtD
Linagliptin—Myalgia—Nicotine—ulcerative colitis	0.000749	0.0066	CcSEcCtD
Linagliptin—Nasopharyngitis—Mesalazine—ulcerative colitis	0.000732	0.00645	CcSEcCtD
Linagliptin—Skin exfoliation—Triamcinolone—ulcerative colitis	0.000721	0.00635	CcSEcCtD
Linagliptin—Skin disorder—Mercaptopurine—ulcerative colitis	0.00072	0.00634	CcSEcCtD
Linagliptin—Skin exfoliation—Methylprednisolone—ulcerative colitis	0.000719	0.00634	CcSEcCtD
Linagliptin—Anaphylactic shock—Nicotine—ulcerative colitis	0.000718	0.00633	CcSEcCtD
Linagliptin—Pancreatitis—Mesalazine—ulcerative colitis	0.000694	0.00611	CcSEcCtD
Linagliptin—Infestation NOS—Azathioprine—ulcerative colitis	0.000692	0.0061	CcSEcCtD
Linagliptin—Infestation—Azathioprine—ulcerative colitis	0.000692	0.0061	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisolone—ulcerative colitis	0.000685	0.00604	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mercaptopurine—ulcerative colitis	0.000675	0.00595	CcSEcCtD
Linagliptin—Diabetes mellitus—Hydrocortisone—ulcerative colitis	0.000669	0.0059	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Mesalazine—ulcerative colitis	0.000657	0.00579	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Nicotine—ulcerative colitis	0.000654	0.00577	CcSEcCtD
Linagliptin—Skin exfoliation—Dexamethasone—ulcerative colitis	0.000654	0.00576	CcSEcCtD
Linagliptin—Skin exfoliation—Betamethasone—ulcerative colitis	0.000654	0.00576	CcSEcCtD
Linagliptin—Weight increased—Mesalazine—ulcerative colitis	0.000644	0.00567	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.00064	0.00564	CcSEcCtD
Linagliptin—Infestation NOS—Mesalazine—ulcerative colitis	0.000631	0.00556	CcSEcCtD
Linagliptin—Infestation—Mesalazine—ulcerative colitis	0.000631	0.00556	CcSEcCtD
Linagliptin—Diabetes mellitus—Triamcinolone—ulcerative colitis	0.00063	0.00555	CcSEcCtD
Linagliptin—Immune system disorder—Budesonide—ulcerative colitis	0.000629	0.00554	CcSEcCtD
Linagliptin—Diabetes mellitus—Methylprednisolone—ulcerative colitis	0.000629	0.00554	CcSEcCtD
Linagliptin—Mediastinal disorder—Budesonide—ulcerative colitis	0.000627	0.00553	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.00062	0.00546	CcSEcCtD
Linagliptin—Constipation—Nicotine—ulcerative colitis	0.000614	0.00541	CcSEcCtD
Linagliptin—Urinary tract infection—Mesalazine—ulcerative colitis	0.000613	0.0054	CcSEcCtD
Linagliptin—Malnutrition—Budesonide—ulcerative colitis	0.000606	0.00534	CcSEcCtD
Linagliptin—Back pain—Budesonide—ulcerative colitis	0.000586	0.00517	CcSEcCtD
Linagliptin—Diabetes mellitus—Betamethasone—ulcerative colitis	0.000572	0.00504	CcSEcCtD
Linagliptin—Diabetes mellitus—Dexamethasone—ulcerative colitis	0.000572	0.00504	CcSEcCtD
Linagliptin—Urticaria—Nicotine—ulcerative colitis	0.000571	0.00503	CcSEcCtD
Linagliptin—Skin exfoliation—Prednisone—ulcerative colitis	0.00057	0.00502	CcSEcCtD
Linagliptin—Immune system disorder—Azathioprine—ulcerative colitis	0.000561	0.00495	CcSEcCtD
Linagliptin—Mediastinal disorder—Azathioprine—ulcerative colitis	0.00056	0.00494	CcSEcCtD
Linagliptin—Angioedema—Budesonide—ulcerative colitis	0.000554	0.00488	CcSEcCtD
Linagliptin—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000546	0.00481	CcSEcCtD
Linagliptin—Hypersensitivity—Nicotine—ulcerative colitis	0.000529	0.00466	CcSEcCtD
Linagliptin—Cough—Budesonide—ulcerative colitis	0.000529	0.00466	CcSEcCtD
Linagliptin—Myalgia—Budesonide—ulcerative colitis	0.000516	0.00455	CcSEcCtD
Linagliptin—Arthralgia—Budesonide—ulcerative colitis	0.000516	0.00455	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000512	0.00451	CcSEcCtD
Linagliptin—Immune system disorder—Mesalazine—ulcerative colitis	0.000511	0.00451	CcSEcCtD
Linagliptin—Mediastinal disorder—Mesalazine—ulcerative colitis	0.00051	0.0045	CcSEcCtD
Linagliptin—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000507	0.00447	CcSEcCtD
Linagliptin—Pancreatitis—Prednisolone—ulcerative colitis	0.000505	0.00445	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisone—ulcerative colitis	0.000498	0.00439	CcSEcCtD
Linagliptin—Anaphylactic shock—Budesonide—ulcerative colitis	0.000495	0.00436	CcSEcCtD
Linagliptin—Pancreatitis—Hydrocortisone—ulcerative colitis	0.000493	0.00435	CcSEcCtD
Linagliptin—Diarrhoea—Nicotine—ulcerative colitis	0.000491	0.00433	CcSEcCtD
Linagliptin—Infection—Budesonide—ulcerative colitis	0.000491	0.00433	CcSEcCtD
Linagliptin—Skin disorder—Budesonide—ulcerative colitis	0.00048	0.00423	CcSEcCtD
Linagliptin—Back pain—Mesalazine—ulcerative colitis	0.000477	0.0042	CcSEcCtD
Linagliptin—Weight increased—Prednisolone—ulcerative colitis	0.000469	0.00413	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000467	0.00412	CcSEcCtD
Linagliptin—Rash—Mercaptopurine—ulcerative colitis	0.000467	0.00412	CcSEcCtD
Linagliptin—Dermatitis—Mercaptopurine—ulcerative colitis	0.000467	0.00411	CcSEcCtD
Linagliptin—Pancreatitis—Triamcinolone—ulcerative colitis	0.000464	0.00409	CcSEcCtD
Linagliptin—Pancreatitis—Methylprednisolone—ulcerative colitis	0.000463	0.00408	CcSEcCtD
Linagliptin—Arthralgia—Azathioprine—ulcerative colitis	0.000461	0.00406	CcSEcCtD
Linagliptin—Myalgia—Azathioprine—ulcerative colitis	0.000461	0.00406	CcSEcCtD
Linagliptin—Weight increased—Hydrocortisone—ulcerative colitis	0.000458	0.00403	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000457	0.00403	CcSEcCtD
Linagliptin—Rash—Nicotine—ulcerative colitis	0.000453	0.00399	CcSEcCtD
Linagliptin—Dermatitis—Nicotine—ulcerative colitis	0.000452	0.00399	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000451	0.00397	CcSEcCtD
Linagliptin—Angioedema—Mesalazine—ulcerative colitis	0.00045	0.00397	CcSEcCtD
Linagliptin—Headache—Nicotine—ulcerative colitis	0.00045	0.00396	CcSEcCtD
Linagliptin—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000448	0.00395	CcSEcCtD
Linagliptin—Infestation—Hydrocortisone—ulcerative colitis	0.000448	0.00395	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.00044	0.00388	CcSEcCtD
Linagliptin—Infection—Azathioprine—ulcerative colitis	0.000439	0.00387	CcSEcCtD
Linagliptin—Weight increased—Triamcinolone—ulcerative colitis	0.000431	0.0038	CcSEcCtD
Linagliptin—Cough—Mesalazine—ulcerative colitis	0.00043	0.00379	CcSEcCtD
Linagliptin—Weight increased—Methylprednisolone—ulcerative colitis	0.00043	0.00379	CcSEcCtD
Linagliptin—Skin disorder—Azathioprine—ulcerative colitis	0.000429	0.00378	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000427	0.00376	CcSEcCtD
Linagliptin—Constipation—Budesonide—ulcerative colitis	0.000423	0.00373	CcSEcCtD
Linagliptin—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000421	0.00371	CcSEcCtD
Linagliptin—Infestation—Methylprednisolone—ulcerative colitis	0.000421	0.00371	CcSEcCtD
Linagliptin—Myalgia—Mesalazine—ulcerative colitis	0.00042	0.0037	CcSEcCtD
Linagliptin—Arthralgia—Mesalazine—ulcerative colitis	0.00042	0.0037	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000417	0.00367	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000402	0.00354	CcSEcCtD
Linagliptin—Anaphylactic shock—Mesalazine—ulcerative colitis	0.000402	0.00354	CcSEcCtD
Linagliptin—Infection—Mesalazine—ulcerative colitis	0.0004	0.00352	CcSEcCtD
Linagliptin—Urticaria—Budesonide—ulcerative colitis	0.000393	0.00346	CcSEcCtD
Linagliptin—Weight increased—Dexamethasone—ulcerative colitis	0.000391	0.00345	CcSEcCtD
Linagliptin—Weight increased—Betamethasone—ulcerative colitis	0.000391	0.00345	CcSEcCtD
Linagliptin—Skin disorder—Mesalazine—ulcerative colitis	0.000391	0.00344	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000381	0.00336	CcSEcCtD
Linagliptin—Pancreatitis—Prednisone—ulcerative colitis	0.000367	0.00323	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000366	0.00323	CcSEcCtD
Linagliptin—Hypersensitivity—Budesonide—ulcerative colitis	0.000364	0.00321	CcSEcCtD
Linagliptin—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000364	0.0032	CcSEcCtD
Linagliptin—Malnutrition—Hydrocortisone—ulcerative colitis	0.00035	0.00309	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000347	0.00306	CcSEcCtD
Linagliptin—Constipation—Mesalazine—ulcerative colitis	0.000344	0.00303	CcSEcCtD
Linagliptin—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000342	0.00301	CcSEcCtD
Linagliptin—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000341	0.003	CcSEcCtD
Linagliptin—Weight increased—Prednisone—ulcerative colitis	0.000341	0.003	CcSEcCtD
Linagliptin—Diarrhoea—Budesonide—ulcerative colitis	0.000338	0.00298	CcSEcCtD
Linagliptin—Malnutrition—Methylprednisolone—ulcerative colitis	0.000329	0.0029	CcSEcCtD
Linagliptin—Angioedema—Prednisolone—ulcerative colitis	0.000328	0.00289	CcSEcCtD
Linagliptin—Hypersensitivity—Azathioprine—ulcerative colitis	0.000325	0.00287	CcSEcCtD
Linagliptin—Angioedema—Hydrocortisone—ulcerative colitis	0.00032	0.00282	CcSEcCtD
Linagliptin—Urticaria—Mesalazine—ulcerative colitis	0.00032	0.00282	CcSEcCtD
Linagliptin—Back pain—Triamcinolone—ulcerative colitis	0.000319	0.00281	CcSEcCtD
Linagliptin—Rash—Budesonide—ulcerative colitis	0.000312	0.00275	CcSEcCtD
Linagliptin—Dermatitis—Budesonide—ulcerative colitis	0.000312	0.00275	CcSEcCtD
Linagliptin—Headache—Budesonide—ulcerative colitis	0.00031	0.00273	CcSEcCtD
Linagliptin—Diarrhoea—Azathioprine—ulcerative colitis	0.000302	0.00266	CcSEcCtD
Linagliptin—Angioedema—Triamcinolone—ulcerative colitis	0.000302	0.00266	CcSEcCtD
Linagliptin—Angioedema—Methylprednisolone—ulcerative colitis	0.000301	0.00265	CcSEcCtD
Linagliptin—Myalgia—Hydrocortisone—ulcerative colitis	0.000298	0.00263	CcSEcCtD
Linagliptin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000296	0.00261	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000296	0.00261	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000293	0.00258	CcSEcCtD
Linagliptin—Cough—Triamcinolone—ulcerative colitis	0.000288	0.00254	CcSEcCtD
Linagliptin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000286	0.00252	CcSEcCtD
Linagliptin—Infection—Hydrocortisone—ulcerative colitis	0.000284	0.0025	CcSEcCtD
Linagliptin—Myalgia—Triamcinolone—ulcerative colitis	0.000281	0.00248	CcSEcCtD
Linagliptin—Myalgia—Methylprednisolone—ulcerative colitis	0.00028	0.00247	CcSEcCtD
Linagliptin—Arthralgia—Methylprednisolone—ulcerative colitis	0.00028	0.00247	CcSEcCtD
Linagliptin—Rash—Azathioprine—ulcerative colitis	0.000278	0.00245	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000278	0.00245	CcSEcCtD
Linagliptin—Dermatitis—Azathioprine—ulcerative colitis	0.000278	0.00245	CcSEcCtD
Linagliptin—Skin disorder—Hydrocortisone—ulcerative colitis	0.000278	0.00245	CcSEcCtD
Linagliptin—Headache—Azathioprine—ulcerative colitis	0.000277	0.00244	CcSEcCtD
Linagliptin—Diarrhoea—Mesalazine—ulcerative colitis	0.000275	0.00242	CcSEcCtD
Linagliptin—Angioedema—Dexamethasone—ulcerative colitis	0.000274	0.00241	CcSEcCtD
Linagliptin—Angioedema—Betamethasone—ulcerative colitis	0.000274	0.00241	CcSEcCtD
Linagliptin—Immune system disorder—Prednisone—ulcerative colitis	0.000271	0.00238	CcSEcCtD
Linagliptin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000269	0.00237	CcSEcCtD
Linagliptin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000269	0.00237	CcSEcCtD
Linagliptin—Infection—Triamcinolone—ulcerative colitis	0.000268	0.00236	CcSEcCtD
Linagliptin—Infection—Methylprednisolone—ulcerative colitis	0.000267	0.00235	CcSEcCtD
Linagliptin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000261	0.0023	CcSEcCtD
Linagliptin—Malnutrition—Prednisone—ulcerative colitis	0.000261	0.0023	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000261	0.0023	CcSEcCtD
Linagliptin—Myalgia—Betamethasone—ulcerative colitis	0.000255	0.00225	CcSEcCtD
Linagliptin—Myalgia—Dexamethasone—ulcerative colitis	0.000255	0.00225	CcSEcCtD
Linagliptin—Rash—Mesalazine—ulcerative colitis	0.000254	0.00223	CcSEcCtD
Linagliptin—Dermatitis—Mesalazine—ulcerative colitis	0.000253	0.00223	CcSEcCtD
Linagliptin—Headache—Mesalazine—ulcerative colitis	0.000252	0.00222	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000247	0.00218	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000245	0.00216	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000245	0.00216	CcSEcCtD
Linagliptin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000244	0.00215	CcSEcCtD
Linagliptin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000244	0.00215	CcSEcCtD
Linagliptin—Infection—Betamethasone—ulcerative colitis	0.000243	0.00214	CcSEcCtD
Linagliptin—Infection—Dexamethasone—ulcerative colitis	0.000243	0.00214	CcSEcCtD
Linagliptin—Angioedema—Prednisone—ulcerative colitis	0.000238	0.0021	CcSEcCtD
Linagliptin—Urticaria—Prednisolone—ulcerative colitis	0.000233	0.00205	CcSEcCtD
Linagliptin—Urticaria—Hydrocortisone—ulcerative colitis	0.000227	0.002	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000223	0.00196	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000223	0.00196	CcSEcCtD
Linagliptin—Arthralgia—Prednisone—ulcerative colitis	0.000222	0.00196	CcSEcCtD
Linagliptin—Myalgia—Prednisone—ulcerative colitis	0.000222	0.00196	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00022	0.00194	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000216	0.0019	CcSEcCtD
Linagliptin—Urticaria—Triamcinolone—ulcerative colitis	0.000214	0.00189	CcSEcCtD
Linagliptin—Urticaria—Methylprednisolone—ulcerative colitis	0.000213	0.00188	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000213	0.00188	CcSEcCtD
Linagliptin—Infection—Prednisone—ulcerative colitis	0.000211	0.00186	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000211	0.00186	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000211	0.00186	CcSEcCtD
Linagliptin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000211	0.00186	CcSEcCtD
Linagliptin—Skin disorder—Prednisone—ulcerative colitis	0.000207	0.00182	CcSEcCtD
Linagliptin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000198	0.00175	CcSEcCtD
Linagliptin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000198	0.00174	CcSEcCtD
Linagliptin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000196	0.00172	CcSEcCtD
Linagliptin—Urticaria—Dexamethasone—ulcerative colitis	0.000194	0.00171	CcSEcCtD
Linagliptin—Urticaria—Betamethasone—ulcerative colitis	0.000194	0.00171	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000194	0.00171	CcSEcCtD
Linagliptin—Rash—Prednisolone—ulcerative colitis	0.000185	0.00163	CcSEcCtD
Linagliptin—Dermatitis—Prednisolone—ulcerative colitis	0.000184	0.00163	CcSEcCtD
Linagliptin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000184	0.00162	CcSEcCtD
Linagliptin—Headache—Prednisolone—ulcerative colitis	0.000183	0.00162	CcSEcCtD
Linagliptin—Constipation—Prednisone—ulcerative colitis	0.000182	0.0016	CcSEcCtD
Linagliptin—Rash—Hydrocortisone—ulcerative colitis	0.00018	0.00159	CcSEcCtD
Linagliptin—Dermatitis—Hydrocortisone—ulcerative colitis	0.00018	0.00159	CcSEcCtD
Linagliptin—Headache—Hydrocortisone—ulcerative colitis	0.000179	0.00158	CcSEcCtD
Linagliptin—Rash—Triamcinolone—ulcerative colitis	0.00017	0.0015	CcSEcCtD
Linagliptin—Dermatitis—Triamcinolone—ulcerative colitis	0.00017	0.00149	CcSEcCtD
Linagliptin—Rash—Methylprednisolone—ulcerative colitis	0.000169	0.00149	CcSEcCtD
Linagliptin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000169	0.00149	CcSEcCtD
Linagliptin—Urticaria—Prednisone—ulcerative colitis	0.000169	0.00149	CcSEcCtD
Linagliptin—Headache—Triamcinolone—ulcerative colitis	0.000169	0.00149	CcSEcCtD
Linagliptin—Headache—Methylprednisolone—ulcerative colitis	0.000168	0.00148	CcSEcCtD
Linagliptin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000167	0.00147	CcSEcCtD
Linagliptin—Diarrhoea—Betamethasone—ulcerative colitis	0.000167	0.00147	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisone—ulcerative colitis	0.000157	0.00138	CcSEcCtD
Linagliptin—Rash—Dexamethasone—ulcerative colitis	0.000154	0.00136	CcSEcCtD
Linagliptin—Rash—Betamethasone—ulcerative colitis	0.000154	0.00136	CcSEcCtD
Linagliptin—Dermatitis—Dexamethasone—ulcerative colitis	0.000154	0.00136	CcSEcCtD
Linagliptin—Dermatitis—Betamethasone—ulcerative colitis	0.000154	0.00136	CcSEcCtD
Linagliptin—Headache—Betamethasone—ulcerative colitis	0.000153	0.00135	CcSEcCtD
Linagliptin—Headache—Dexamethasone—ulcerative colitis	0.000153	0.00135	CcSEcCtD
Linagliptin—Diarrhoea—Prednisone—ulcerative colitis	0.000146	0.00128	CcSEcCtD
Linagliptin—Rash—Prednisone—ulcerative colitis	0.000134	0.00118	CcSEcCtD
Linagliptin—Dermatitis—Prednisone—ulcerative colitis	0.000134	0.00118	CcSEcCtD
Linagliptin—Headache—Prednisone—ulcerative colitis	0.000133	0.00117	CcSEcCtD
